Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Aug, 11 2026
Dec, 20 2025
Mar, 21 2025
Sep, 25 2025
Sep, 27 2025